PharmaVoice

JULY 7, 2025

Launches DSai™ — AI-Powered Digital Sign-In to Modernize HCP Event Compliance in L… From Groupize.ai Company Announcements View all | Post a press release ActiGraph rebrands as Ametris to reflect expanded clinical evidence generation capabilities From Ametris June 25, 2025 Groupize.ai

Insurance

Pharmaceutical Technology

JUNE 25, 2025

The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid (BP), a condition that predominantly affects the elderly. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review.

FDA

Pharma Marketing Network

DECEMBER 4, 2024

Omnichannel Marketing Strategies Omnichannel marketing ensures consistency across all platforms—whether it’s an email, social media post, or in-person event. Adhering to guidelines from the FDA and other governing bodies ensures that campaigns remain effective without crossing ethical boundaries.

Communication

PharmaVoice

JULY 8, 2025

The FDA approved the first MEK inhibitor, a melanoma drug from Novartis, in 2013. Launches DSai™ — AI-Powered Digital Sign-In to Modernize HCP Event Compliance in L… From Groupize.ai © 2025 TechTarget, Inc. or its subsidiaries. All rights reserved. View our other publications | Privacy policy | Terms of use | Take down policy.

Immunization

Pharmaceutical Technology

JULY 29, 2025

The US Food and Drug Administration (FDA) has granted approval for Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd, developed as TransCon hGH), a prodrug of somatropin or human growth hormone (HGH), to treat adults with growth hormone deficiency (GHD). Credit: Andrei Kuzmik / Shutterstock.com.

FDA

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Credit: design_cam/Shutterstock.com. Icotrokinra was co-discovered and is currently being developed through a licensing and collaboration agreement between Protagonist and J&J.

FDA

Pharmaceutical Technology

JULY 30, 2025

This follows the ODD granted by the US Food and Drug Administration (FDA) and highlights MP1032’s potential as a first-in-class therapy that may reduce the need for high-dose corticosteroids, which can lead to serious side effects such as growth stunting, osteoporosis and metabolic issues.

Packaging

Pharmaceutical Technology

AUGUST 12, 2025

Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 10, 2025

MSD has received US Food and Drug Administration (FDA) approval for Enflonsia (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants. Can pharma tariffs “Make America Manufacture Again”? Credit: MargJohnsonVA/Shutterstock.

FDA

Pharma Manufacturing

JUNE 17, 2025

Despite the potential efficiencies and the FDA encouraging manufacturers to make the switch from batch processing, the pharmaceutical industry has been slow to adopt continuous manufacturing due in large part to general conservatism and the cost implications of such investments. “Those are through the FDA,” he said.

Dosage

SingleCare

JULY 7, 2022

For some patients, experiencing a serious adverse event from a drug can be a harrowing, or even life-threatening, event. To prevent potential adverse events and protect public health, the FDA has implemented drug recall processes to obtain, replace, and dispose of defective, incorrectly labeled, or ineffective drugs.

Documentation

The Checkup by Singlecare

AUGUST 7, 2025

Seasonal events like picnics, cookouts, and camping increase the chances of improper food handling. Outdoor events like barbecues, tailgates, and picnics often involve long periods where perishable foods sit out unrefrigerated. Choose piping-hot, freshly cooked meals when available; otherwise, choose pre-packaged foods.

Immunization

Pharmaceutical Technology

JULY 29, 2025

The safety profile remained consistent with previous studies, with no unexpected events observed. Efficacy was demonstrated across the full spectrum of axSpA, including both radiographic (r-axSpA) and non-radiographic (nr-axSpA) forms. Rinvoq also beat Jyseleca to the market in axSpA, having gained approval in the indication in 2022.

Packaging

PharmTech

JUNE 19, 2025

The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. Communication between the manufacturing plant and retail stores. as part of the company’s commitment to providing a reliable supply of bioprocessing ingredients and excipients to the biopharma and pharmaceutical industries.

Dosage

Pharmaceutical Technology

JULY 31, 2025

Annabel Kartal Allen July 31, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The FDA has appointed George Tidmarsh as the temporary director of CBER after Vinay Prasad’s sudden exit. Image credit: -Oxford- via Getty Images. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

FDA

PharmaVoice

JUNE 27, 2025

Despite worried hand-wringing over a potential slowdown in FDA approvals under the new administration, the agency has been giving the go-ahead to drugs at a near record-setting clip. Meanwhile, the decision-making production has come during a major upheaval inside the FDA. Please let us know if you have feedback.

FDA

Pharmaceutical Technology

JUNE 12, 2025

Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 9, 2025

YolTech Therapeutics has received the US Food and Drug Administration (FDA) approval for its investigational new drug (IND) application for YOLT-101 to treat heterozygous familial hypercholesterolemia (HeFH). Credit: aipicte/Shutterstock. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

FDA

PharmTech

JUNE 6, 2025

These may either be specific to the production process itself (such as pyroglutamination of the N-terminus as is frequently seen in monoclonal antibodies (mAbs) or may be the result of purification processes (such as amino acid oxidation or deamidation events) and may indicate that process change is required. Specifications.

Dosage

Pharmacy Times

JULY 19, 2025

As a multifactorial condition influenced by both genetic predisposition and lifestyle factors, hypertension is a leading risk factor for serious health outcomes including microvascular complications (retinopathy and nephropathy) and macrovascular events (myocardial infarction and stroke). mg/d, 1 mg/d, 2 mg/d, and placebo for 12 weeks.

HIV Treatment and Prevention Agents

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JUNE 10, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Communication

Pharmacy Times

JULY 7, 2025

Takeda has informed the FDA that the manufacturing of Gammagard S/D will cease in December 2027. The new formulation is contraindicated in patients with severe hypersensitivity to immunoglobulin products, requiring careful monitoring.

FDA

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices?

Communication

Pharmaceutical Technology

JULY 25, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Meanwhile, the US Food and Drug Administration (FDA) has extended the review period for the biologics licence application (BLA) submitted by the company for Blenrep combinations for the same indication.

Packaging

Pharmaceutical Technology

AUGUST 12, 2025

Give your business an edge with our leading industry insights.

Immunization

Pharmaceutical Technology

JUNE 18, 2025

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational oral medicine, zagociguat, for mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), a rare mitochondrial disease. Credit: Volha_R/Shutterstock.

FDA

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights.

Packaging

PharmExec

JULY 31, 2025

This is what the FDA requires for botanical drug approval: evidence, consistency, and repeatability. A Market Ready For Change In this way, a botanical drug is not a supplement with better packaging. It is a pharmaceutical, developed within a rigorous regulatory framework.

Compounding

PharmTech

JUNE 23, 2025

FDA guidance documents illustrate labeling salt drugs and associated active moieties. The secondary label will specify the Drug ZA-ion amount per capsule and the equivalent Drug Z-salt amount consistent with FDA labeling guidance. Additional mole calculations are needed only for drug-name labeling per FDA guidance ( Figure 5b above).

Compounding

Pharmacy Times

JULY 15, 2025

What we've done is blend PillPack's innovative packaging with Amazon Pharmacy's user-friendly approach and affordability, so these patients can now get their medications in convenient, personalized packets and order everything online through our digital pharmacy.

Compounding Pharmacies

Pharmaceutical Technology

JULY 1, 2025

Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. In a bid to chase competitiveness, the EU is advancing its most drastic revision of pharmaceutical law in 20 years.

Packaging

PharmaVoice

JULY 24, 2025

Despite past criticism of public health policies, Tidmarsh recently praised the FDA and said he’ll focus on boosting review efficiencies. Despite past criticism of public health policies, Tidmarsh recently praised the FDA and said he’ll focus on boosting review efficiencies. Here’s how one company built its own.

Packaging

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. Concerningly, preventable adverse events due to medication errors cause an estimated 44,000 to 98,000 hospital deaths annually, more than the number attributed to motor vehicle accidents.

Packaging